![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/513 | |
A61K 31/675 | |||
A61K 31/553 | |||
A61K 9/20 | |||
A61P 31/18 | |||
A61K 9/24 |
(11) | Patento numeris | 3346995 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16798063.0 |
Europos patento paraiškos padavimo data | 2016-11-08 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-07-18 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-28 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/060989 |
Data | 2016-11-08 |
(87) | Numeris | WO 2017/083304 |
Data | 2017-05-18 |
(30) | Numeris | Data | Šalis |
201562253042 P | 2015-11-09 | US | |
201662399999 P | 2016-09-26 | US |
(72) |
HONG, Lei, US
COLLMAN, Benjamin, Micah, US
KOZIARA, Joanna, M., US
|
(73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
(54) | THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS |
THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS |